AIM2 and hepatocellular carcinoma: These seemingly contrasting roles are, however, not exclusive, and they may reflect a different role for AIM2 in different disease stages (established/advanced HCC vs. early stage) or in different cell types (HCC cells vs. nonparenchymal liver immune cells).